Travere Therapeutics, Inc.
SEC 4 · Filed
0001477384-26-000008Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date May 19, 2026
Grant, award or other acquisition by Orwin John A
- Security
- Stock option (right to buy)
- Shares
-
12,000
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-05-19",
"direction": "A",
"exercise_price": "42.26",
"expiration": "2036-05-19",
"footnotes": {
"F1": "Automatic equity grant under the Issuer\u0027s 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.",
"F2": "The equity award vests over a one year period."
},
"owners": [
{
"cik": "0001477384",
"name": "Orwin John A",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "12000",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Stock option (right to buy)",
"shares": "12000",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "12000"
}Insider transactionsEvent date May 19, 2026
Grant, award or other acquisition by Orwin John A
- Security
- Common Stock
- Shares
-
4,000
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-05-19",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Automatic equity grant under the Issuer\u0027s 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.",
"F2": "The equity award vests over a one year period."
},
"owners": [
{
"cik": "0001477384",
"name": "Orwin John A",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "39375",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "4000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}